Dana M Hornbeak1, Terri L Young. 1. Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, USA.
Abstract
PURPOSE OF REVIEW: Myopia, or nearsightedness, is the most common human eye disorder in the world and is a significant global public health concern. Along with cataract, macular degeneration, infectious disease, and vitamin A deficiency, myopia is one of the most important causes of visual impairment worldwide. Severe or high-grade myopia is a leading cause of blindness because of its associated ocular comorbidities of retinal detachment, macular choroidal degeneration, premature cataract, and glaucoma. Ample epidemiologic and molecular genetic studies support heritability of the nonsyndromic forms of this condition. RECENT FINDINGS: Multiple myopia genetic loci have been identified, establishing this entity as a common complex disorder and underscoring the suitability for gene inquiry studies. Animal model research, primarily using form-deprivation techniques, implicates multiple altered regulation of biological substances in the ocular wall layers, which provides important information for prioritizing human candidate gene studies. Recent epidemiologic work supports a greater role for outdoor activity in relieving myopia progression rather than the previous touted young-age near-work activity model. SUMMARY: The identification of myopia susceptibility genes will not only provide insight into the molecular basis of this significant eye disorder, but will also identify pathways involved in eye growth and development. This effort may lead to effective therapies to treat or potentially prevent this common eye condition.
PURPOSE OF REVIEW: Myopia, or nearsightedness, is the most common humaneye disorder in the world and is a significant global public health concern. Along with cataract, macular degeneration, infectious disease, and vitamin A deficiency, myopia is one of the most important causes of visual impairment worldwide. Severe or high-grade myopia is a leading cause of blindness because of its associated ocular comorbidities of retinal detachment, macular choroidal degeneration, premature cataract, and glaucoma. Ample epidemiologic and molecular genetic studies support heritability of the nonsyndromic forms of this condition. RECENT FINDINGS:Multiple myopia genetic loci have been identified, establishing this entity as a common complex disorder and underscoring the suitability for gene inquiry studies. Animal model research, primarily using form-deprivation techniques, implicates multiple altered regulation of biological substances in the ocular wall layers, which provides important information for prioritizing human candidate gene studies. Recent epidemiologic work supports a greater role for outdoor activity in relieving myopia progression rather than the previous touted young-age near-work activity model. SUMMARY: The identification of myopia susceptibility genes will not only provide insight into the molecular basis of this significant eye disorder, but will also identify pathways involved in eye growth and development. This effort may lead to effective therapies to treat or potentially prevent this common eye condition.
Authors: Christine Y Chen; Jim Stankovich; Katrina J Scurrah; Pam Garoufalis; Mohamed Dirani; Kelly K Pertile; Andrea J Richardson; Paul N Baird Journal: Invest Ophthalmol Vis Sci Date: 2007-10 Impact factor: 4.799
Authors: Gudrun Nürnberg; Felix K Jacobi; Martina Broghammer; Christian Becker; Nikolaus Blin; Peter Nürnberg; Ulrich Stephani; Carsten M Pusch Journal: Int J Mol Med Date: 2008-04 Impact factor: 4.101
Authors: Kelly K Pertile; Maria Schäche; F M Amirul Islam; Christine Y Chen; Mohamed Dirani; Paul Mitchell; Paul N Baird Journal: Invest Ophthalmol Vis Sci Date: 2008-01 Impact factor: 4.799
Authors: Sarah P Meredith; Allan J Richards; Philip Bearcroft; Arabella V Pouson; Martin P Snead Journal: Br J Ophthalmol Date: 2007-03-08 Impact factor: 4.638
Authors: Wing Chun Tang; Shea Ping Yip; Ka Kin Lo; Po Wah Ng; Pik Shan Choi; Sau Yin Lee; Maurice K H Yap Journal: Mol Vis Date: 2007-04-04 Impact factor: 2.367
Authors: Claire L Simpson; Pirro Hysi; Shomi S Bhattacharya; Chris J Hammond; Andrew Webster; Catherine S Peckham; Pak C Sham; Jugnoo S Rahi Journal: Invest Ophthalmol Vis Sci Date: 2007-10 Impact factor: 4.799
Authors: David M Hudson; Kyu Sang Joeng; Rachel Werther; Abbhirami Rajagopal; MaryAnn Weis; Brendan H Lee; David R Eyre Journal: J Biol Chem Date: 2015-02-02 Impact factor: 5.157
Authors: Michelle McClements; Wayne I L Davies; Michel Michaelides; Terri Young; Maureen Neitz; Robert E MacLaren; Anthony T Moore; David M Hunt Journal: Invest Ophthalmol Vis Sci Date: 2013-02-15 Impact factor: 4.799
Authors: Elliott H Sohn; Miles J Flamme-Wiese; S Scott Whitmore; Grefachew Workalemahu; Alexander G Marneros; Erin A Boese; Young H Kwon; Kai Wang; Michael D Abramoff; Budd A Tucker; Edwin M Stone; Robert F Mullins Journal: Am J Pathol Date: 2019-04-30 Impact factor: 4.307
Authors: Felicia Hawthorne; Sheng Feng; Ravikanth Metlapally; Yi-Ju Li; Khanh-Nhat Tran-Viet; Jeremy A Guggenheim; Francois Malecaze; Patrick Calvas; Thomas Rosenberg; David A Mackey; Cristina Venturini; Pirro G Hysi; Christopher J Hammond; Terri L Young Journal: Invest Ophthalmol Vis Sci Date: 2013-03-21 Impact factor: 4.799